Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_assertion type Assertion NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_head.
- NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_assertion wasGeneratedBy ECO_0000203 NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_provenance.
- NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_assertion wasDerivedFrom befree-20140225 NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_provenance.
- NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_assertion SIO_000772 18796137 NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_provenance.
- NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_assertion evidence source_evidence_literature NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_provenance.
- NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_assertion description "[Patients who developed recurrence and died of breast cancer had significantly lower levels of EPLIN-alpha compared with those who remained disease free (p = 0.0003 and p = 0.0008, respectively) (median follow-up 10 years).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP544934.RAsP7BpmxS6iVphyjfbvwS3hmGeuWF1II6EEv-p8jrd1A130_provenance.